{"doi":"10.1093/ajh/hpaf016","title":"Accuracy of a Novel High-Throughput “Car Blood Pressure” Measurement Protocol","abstract":"BACKGROUND: More than one in three adults with hypertension in the United States are unaware of their condition, highlighting the importance of large-scale screening campaigns. Currently, the identification of hypertension is largely limited to medical settings. To help overcome this barrier, we developed a novel high-throughput screening protocol that measures blood pressure (BP) while patients remain seated in an automobile (\"car-BP\"). The aim of this study was to provide an initial assessment of the accuracy of car-BP. METHODS: Three BP readings were determined in a clinic exam room before and after three BP readings were taken while patients were seated in a parked car outside (n = 100 participants). The same validated device model (Omron HEM-907XL) and BP measurement methods adhering to guidelines were used in both scenarios. The average of all 6 clinic readings was compared to the average of the 3 car-BP readings in each individual. RESULTS: Mean clinic and car-BP readings were 120.9 ± 16.2/78.0 ± 9.9 and 118.9 ± 15.2/76.0 ± 10.0 mm Hg, respectively. The paired mean and absolute mean differences in systolic BP levels between methods were -1.92 mm Hg (95% confidence interval (CI) -3.2 to -0.7 mm Hg) and 4.8 mm Hg (95%CI 3.8 to 5.6 mm Hg), respectively. A total of 85% of participants had both systolic and diastolic BP levels ≤ 10 mm Hg different between measurement scenarios (meeting the a priori determined study primary outcome). CONCLUSIONS: Car-BP represents an innovative and accessible approach for potential large-scale hypertension screening campaigns.","journal":"American Journal of Hypertension","year":2025,"id":518959,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9609,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":978907,"name":"Shaun Cardozo","orcid":"0000-0001-7239-1192","position":1,"is_corresponding":false},{"id":1386859,"name":"A.B. Johnson","orcid":"0000-0003-3089-2081","position":2,"is_corresponding":false},{"id":76009,"name":"Brian D. Reed","orcid":"0000-0002-6323-6307","position":3,"is_corresponding":false},{"id":536720,"name":"Steven J. Korzeniewski","orcid":"0000-0002-8895-6052","position":4,"is_corresponding":false},{"id":1387312,"name":"P Levy","orcid":null,"position":5,"is_corresponding":false},{"id":267329,"name":"Robert D. Brook","orcid":"0000-0002-8521-7262","position":6,"is_corresponding":false},{"id":1386858,"name":"Neiberg de Alcantara Lima","orcid":"0000-0003-3616-435X","position":0,"is_corresponding":true}],"reference_count":7,"raw_metadata":null,"created_at":"2026-07-19T02:49:14.184995Z","pmid":"39886990","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}